Clinical Significance of Tumour Markers | Semantic Scholar
CA 19-9 tumour-marker response to chemotherapy in patients with advanced pancreatic cancer enrolled in a randomised controlled trial - The Lancet Oncology
Old Dog, New Tricks: Use of CA 19-9 for Early Diagnosis of Pancreatic Cancer - Gastroenterology
Causative conditions of elevated CA 19-9 levels in the elevated CA 19-9... | Download Scientific Diagram
CA19-9 and CA242 as tumor markers for the diagnosis of pancreatic cancer: a meta-analysis | SpringerLink
Sekbio CA19-9 Tumor/Cancer Marker, Cancer Antigen 19-9, CA 19-9 Blood Test China
IJMS | Free Full-Text | CA 19-9 Pancreatic Tumor Marker Fluorescence Immunosensing Detection via Immobilized Carbon Quantum Dots Conjugated Gold Nanocomposite
Tumor markers in pancreatic cancer: 2013. | Semantic Scholar
Tumor markers
Carbohydrate antigen 19-9 elevation without evidence of malignant or pancreatobiliary diseases | Scientific Reports
Tumor marker 腫瘤標記@ ~Teachingcenter的醫學筆記~ :: 痞客邦::
Carbohydrate antigen 19-9 — tumor marker: Past, present, and future
Tumor Markers:- Part 7 - CA 125 and CA 19-9 - Labpedia.net
Unjust Be Quite ca19 9 tumor marker levels Machu Picchu plaster Gain control
Comparison of two immunoassays for CA19-9, CEA and AFP tumor markers - Biochemia Medica
Lead-Time Trajectory of CA19-9 as an Anchor Marker for Pancreatic Cancer Early Detection - ScienceDirect
Clinical significance and diagnostic value of serum NSE, CEA, CA19-9, CA125 and CA242 levels in colorectal cancer. - Document - Gale OneFile: Health and Medicine
Clinical Value of Serum CEA, CA 19-9, CA 242 and AFP in Diagnosis of Gastrointestinal Tract Cancers
CA 19-9 – Pancreatic Cancer Action Network
Patients with normal‑range CA19‑9 levels represent a distinct subgroup of pancreatic cancer patients
Evaluating the efficacy of tumor markers CA 19-9 and CEA to predict operability and survival in pancreatic malignancies
Serum levels of CEA and CA19.9 tumor markers in individual patients | Download Table
Frontiers | Diagnostic Significance of Serum IgG Galactosylation in CA19-9-Negative Pancreatic Carcinoma Patients
Introduction and overview of CA19-9 CA19-9 is a tumour associated antigen found in the blood serum. CA 19-9 is also known as the Sialylated Lewis-antigen. - ppt download
CA19–9 decrease and survival according to platelet level in patients with advanced pancreatic cancer | BMC Cancer | Full Text
